All transvaginal mesh manufacturers in the U.S. have been ordered to cease selling and distributing their products within the U.S. effective April 16, 2019. The U.S. Food and Drug Administration (FDA) took this drastic step after undertaking an escalating number of safety initiatives following a... Read More

A lawsuit filed against hernia mesh maker C.R. Bard, Davol Inc., and Covidien, LP has been removed to federal court where it may join a consolidated legal action pending against the defendants. The product liability claim was initially filed in the 234th Judicial District Court... Read More

A few dozen Ethicon hernia mesh lawsuits have been selected for the initial discovery pool. From this pool, a handful of bellwether cases will be selected for early trial dates. These bellwether trials are intended to allow all involved parties to assess how juries tend... Read More

The Scottish Parliament has received a petition requesting the total ban of the use of transvaginal mesh implants within the country. The request was filed by the Holyrood Public Petition Committee, which was prompted to take action by the thousands of reports of serious complications... Read More

The U.S. Judicial Panel on Multidistrict Litigation (JPML) recently heard arguments regarding the possible consolidation of federal hernia mesh lawsuits filed against C.R. Bard and its Davol subsidiary. If the JPML decides to consolidate the cases, it would add to the growing number of multidistrict... Read More

The use of vaginal mesh surgical products has been immediately suspended in the United Kingdom. The decision comes on the heels of widespread concerns of significant, long-term health complications that have been reported by thousands of women who have received these implants to treat stress... Read More

A New Jersey jury recently ordered C.R. Bard to pay a total of $68 million in damages as a result of the complications suffered by a woman who had two of the company’s products, an Avaulta Solo mesh, and an Align Transobturator, implanted in March... Read More

Endo Pharmaceuticals has recently announced that it will set aside another $775 million for plaintiffs who have filed vaginal mesh injury lawsuits. This addition brings the total the plaintiffs are expected to receive to $2.6 billion. The new total is expected to resolve all or... Read More